NCT05672875View on ClinicalTrials.gov

Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System

TerminatedOBSERVATIONAL
Enrollment

343

Participants

Timeline

Start Date

January 23, 2023

Primary Completion Date

April 20, 2023

Study Completion Date

April 20, 2023

Conditions
Anthrax
Interventions
DIAGNOSTIC_TEST

Anthrax LF Dx System

Lateral flow immunoassay for the detection of the LF biomarker in whole blood samples.

Trial Locations (3)

43214

WellNow Urgent Care and Research, Columbus

45215

WellNow Urgent Care and Research, Cincinnati

45373

WellNow Urgent Care and Research, Dayton

Sponsors

Lead Sponsor

SRI International
All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

SRI International

INDUSTRY

NCT05672875 - Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System | Biotech Hunter | Biotech Hunter